Leptin enhances insulin sensitivity by direct and sympathetic nervous system regulation of muscle IGFBP-2 expression: Evidence from nonrodent models

Endocrinology

Volumn 155, Issue 6, 2014, Pages 2133-2143

  Yau, Steven W ^a,b,c   Henry, Belinda A ^c   Russo, Vincenzo C ^a,b   McConell, Glenn K ^d   Clarke, Iain J ^c   Werther, George A ^a,b   Sabin, Matthew A ^a,b,c  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d VICTORIA UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN; STAT3 PROTEIN; INSULIN; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 2;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HORMONAL REGULATION; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHEEP; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; CELL CULTURE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; LEPTIN; MUSCLE, SKELETAL; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SHEEP; SYMPATHETIC NERVOUS SYSTEM;

EID: 84900024301     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-2099     Document Type: Article

References (57)

1. Harris RB. Role of set-point theory in regulation of body weight. FASEB J. 1990;4: 3310-3318.
2. Mantzoros CS, Magkos F, Brinkoetter M, et al. Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab. 2011;301: E567-E584.
3. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395: 763-770.
4. Könner AC, Brüning JC. Selective insulin and leptin resistance in metabolic disorders. Cell Metab. 2012;16: 144-152.
5. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269: 543-546.
6. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995;269: 540-543.
7. Schwartz MW, Baskin DG, Bukowski TR, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 1996;45: 531-535.
8. Bjørbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res. 2004;59: 305-331.
9. Bates SH, Gardiner JV, Jones RB, Bloom SR, Bailey CJ. Acute stimulation of glucose uptake by leptin in l6 muscle cells. Horm Metab Res. 2002;34: 111-115.
10. Ceddia RB, WilliamWNJr, Curi R. Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation. Int J Obes Relat Metab Disord. 1999;23: 75-82.
11. Muoio DM, Dohm GL, Tapscott EB, Coleman RA. Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. Am J Physiol. 1999;276: E913-E921.
12. Steinberg GR, Dyck DJ. Development of leptin resistance in rat soleus muscle in response to high-fat diets.Am J Physiol Endocrinol Metab. 2000;279: E1374-E1382.
13. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 1997;389: 374-377.
14. Minokoshi Y, Haque MS, Shimazu T. Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes. 1999;48: 287-291.
15. Haque MS, Minokoshi Y, Hamai M, Iwai M, Horiuchi M, Shimazu T. Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes. 1999;48: 1706-1712.
16. Berglund ED, Vianna CR, Donato J Jr, et al. Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J Clin Invest. 2012;122: 1000-1009.
17. German JP, Thaler JP, Wisse BE, et al. Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology. 2011;152: 394-404.
18. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 1997;46: 2040-2043.
19. HaynesWG, Morgan DA, Walsh SA, MarkAL, Sivitz WI. Receptormediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100: 270-278.
20. Fujikawa T, Berglund ED, Patel VR, et al. Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin. Cell Metab. 2013;18: 431-444.
21. Hedbacker K, Birsoy K, Wysocki RW, et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab. 2010;11: 11-22.
22. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002;23: 824-854.
23. BoneyCM, Moats-StaatsBM, Stiles AD, D'Ercole AJ. Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. Endocrinology. 1994;135: 1863-1868.
24. Wheatcroft SB, KearneyMT, ShahAM, et al. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes. 2007;56: 285-294.
25. Nam SY, Lee EJ, Kim KR, et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGFbinding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord. 1997;21: 355-359.
26. Claudio M, Benjamim F, Riccardo B, Massimiliano C, Francesco B, Luciano C. Adipocytes IGFBP-2 expression in prepubertal obese children. Obesity (Silver Spring). 2010;18: 2055-2057.
27. Ballerini MG, Ropelato MG, Domené HM, Pennisi P, Heinrich JJ, Jasper HG. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis. J Pediatr Endocrinol Metab. 2004; 17: 749-757.
28. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev. 1999;15: 314-322.
29. Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Exp Clin Endocrinol Diabetes. 2006;114: 371: 376.
30. Sabin MA, Russo VC, Azar WJ, Yau SW, Kiess W, Werther GA. IGFBP-2 at the interface of growth and metabolism-implications for childhood obesity. Pediatr Endocrinol Rev. 2011;8: 382-393.
31. Neumann UH, Chen S, Tam YY, et al. IGFBP2 is neither sufficient nor necessary for the physiological actions of leptin on glucose homeostasis in male ob/ob mice. Endocrinology. 2014;155: 716-725.
32. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 1981;30: 1000-1007.
33. Crown AL, He XL, Holly J, Lightman SL, Stewart CE. Characterisation of the IGF system in a primary adult human skeletal muscle cell model, and comparison of the effects of insulin and IGF-I on protein metabolism. J Endocrinol. 2000;167: 403-415.
34. Babic T, Purpera MN, Banfield BW, Berthoud HR, Morrison CD. Innervation of skeletal muscle by leptin receptor-containing neurons. Brain Res. 2010;1345: 146-155.
35. Henry BA, Andrews ZB, Rao A, Clarke IJ. Central leptin activates mitochondrial function and increases heat production in skeletal muscle. Endocrinology. 2011;152: 2609-2618.
36. Henry BA, Dunshea FR, Gould M, Clarke IJ. Profiling postprandial thermogenesis in muscle and fat of sheep and the central effect of leptin administration. Endocrinology. 2008;149: 2019-2026.
37. Henry BA, Goding JW, Alexander WS, et al. Central administration of leptin to ovariectomized ewes inhibits food intake without affecting the secretion of hormones from the pituitary gland: evidence for a dissociation of effects on appetite and neuroendocrine function. Endocrinology. 1999;140: 1175-1182.
38. Clarke IJ, Tilbrook AJ, Turner AI, Doughton BW, Goding JW. Sex, fat and the tilt of the earth: effects of sex and season on the feeding response to centrally administered leptin in sheep. Endocrinology. 2001;142: 2725-2728.
39. Clarke SD, Clarke IJ, RaoA, CowleyMA, Henry BA. Sex differences in the metabolic effects of testosterone in sheep. Endocrinology. 2012;153: 123-131.
40. Clarke SD, Clarke IJ, Rao A, Evans RG, Henry BA. Differential effects of acute and chronic estrogen treatment on thermogenic and metabolic pathways in ovariectomized sheep. Endocrinology. 2013; 154: 184-192.
41. Laker RC, Henry BA, Wadley GD, Clarke IJ, Canny BJ, McConell GK. Central infusion of leptin does not increase AMPK signaling in skeletal muscle of sheep. Am J Physiol Regul Integr Comp Physiol. 2011;300: R511-R518.
42. Sechen SJ, Dunshea FR, Bauman DE. Somatotropin in lactating cows: effect on response to epinephrine and insulin. Am J Physiol Endocrinol Metab. 1990;258: E582-E588.
43. Tartaglia LA. The leptin receptor. J Biol Chem. 1997;272: 6093-6096.
44. Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, MyersMGJr, Schwartz MW. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature. 2001;413: 794-795.
45. Levi J, Huynh FK, Denroche HC, et al. Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice. Diabetologia. 2012;55: 752-762.
46. Sabin MA, Yau SW, Russo VC, et al. Dietary monounsaturated fat in early life regulates IGFBP2: implications for fat mass accretion and insulin sensitivity. Obesity (Silver Spring). 2011;19: 2374-2381.
47. Maroni P, Bendinelli P, Piccoletti R. Intracellular signal transduction pathways induced by leptin in C2C12 cells. Cell Biol Int. 2005; 29: 542-550.
48. Kellerer M, Koch M, Metzinger E, Mushack J, Capp E, Häring HU. Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia. 1997;40: 1358-1362.
49. Roman EA, Reis D, Romanatto T, et al. Central leptin action improves skeletal muscle AKT, AMPK, and PGC1β activation by hypothalamic PI3K-dependent mechanism. Mol Cell Endocrinol. 2010;314: 62-69.
50. Sweeney G, Keen J, Somwar R, Konrad D, Garg R, Klip A. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in L6 rat skeletal muscle cells. Endocrinology. 2001;142: 4806-4812.
51. Sasaoka T, Wada T, Tsuneki H. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity. Pharmacol Ther. 2006;112: 799-809.
52. Perks CM, Vernon EG, Rosendahl AH, Tonge D, Holly JM. IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells. Oncogene. 2007;26: 5966-5972.
53. Wheatcroft SB, Kearney MT. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends Endocrinol Metab. 2009;20: 153-162.
54. Berti L, Gammeltoft S. Leptin stimulates glucose uptake in C2C12 muscle cells by activation of ERK2. Mol Cell Endocrinol. 1999; 157: 121-130.
55. Pintar JE, Schuller A, Cerro JA, Czick M, Grewal A, Green B. Genetic ablation of IGFBP-2 suggests functional redundancy in the IGFBP family. Prog Growth Factor Res. 1995;6: 437-445.
56. Harlan SM, Rahmouni K. Neuroanatomical determinants of the sympathetic nerve responses evoked by leptin. Clin Auton Res. 2012;: 1-7.
57. Qi Y, Henry BA, Oldfield BJ, Clarke IJ. The action of leptin on appetite-regulating cells in the ovine hypothalamus: demonstration of direct action in the absence of the arcuate nucleus. Endocrinology. 2010;151: 2106-2116.